Bonjesta

Product manufactured by Duchesnay Usa, Inc.

Application Nr Approved Date Route Status External Links
NDA209661 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Bonjesta Is Indicated For The Treatment Of Nausea And Vomiting Of Pregnancy In Women Who Do Not Respond To Conservative Management. Limitations Of Use Bonjesta Has Not Been Studied In Women With Hyperemesis Gravidarum. Bonjesta Is A Fixed Dose Combination Drug Product Of 20 Mg Doxylamine Succinate, An Antihistamine, And 20 Mg Pyridoxine Hydrochloride, A Vitamin B 6 Analog, Indicated For The Treatment Of Nausea And Vomiting Of Pregnancy In Women Who Do Not Respond To Conservative Management. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments